Gov't releases generic drug price comparison study results
By Lee, Tak-Sun | translator Kang, Shin-Kook
24.06.27 05:59:38
가나다라
0
Final meeting scheduled for Nov. 27... Exclusion of the highest and lowest price among A8 countries will likely be used as a comparison
Excluding the highest price, such as those set in the U.S. and elsewhere, could lead to price cuts for hyperlipidemia drugs, deteriorating sales performance of generics
The government's decision to fully disclose the 'Study on Measures to Improve the Generic Drug Pricing System,' which ended in April, ahead of the final meeting for the external reference pricing reevaluations, is being analyzed as a sign that the authorities intend to push ahead its plan to cut generic drug price through reevaluations.
In particular, the industry believes the government is using media to publicize the study findings that the generic drug price is up to 10 times more expensive in Korea than in other countries, excluding the U.S., as a means to justify the reevaluation.
According to industry sources on the 25th, the 10th meeting on the external reference pricing re
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)